The following six types of cancer with genetic alteration had especially high copy number amplification of BRD9: ACC, lymphoid neoplasm diffuse large B‐cell lymphoma (DLBC), KIRC, MESO, pancreatic adenocarcinoma (PAAD) and thyroid carcinoma (THCA). This evidence concerns the gene BRD9 and adrenal cortex carcinoma.